Rando: Biological age biomarkers will enormously accelerate longevity research
Dr. Thomas Rando · a16z Podcast | The Science Of Extending Life · Jan 2, 2019 · at 6:13
Dr. Thomas Rando, director of the Glenn Center for the Biology of Aging at Stanford, explains how biological age biomarkers accelerate clinical trials in geroscience.
0:00 / 0:05exact quote · 5.4s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“And I think, you know, the idea of having biomarkers is going to accelerate this field enormously.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Dr. Thomas Rando
Rando: Infusing young blood into old animals reverses some aging phenotypes
“What we really know these days is that it does seem that if you infuse Components of a blood from a young animal into an old animal. It actually can revert some of the aging phenotypes from an old state to a younger state, which is something quite different be…”
Rando: Young plasma clinical trial underway for early-onset Alzheimer's patients
“The company based on the kind of this work of the blood transfusions is currently conducting a trial of delivering Plasma from young individuals to patients with early onset Alzheimer's disease.”